Prognostic Impact of Bone Marrow Fibrosis And Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia

Myelofibrosis is reported in around 40% of newly diagnosed chronic myeloid leukemia (CML) patients and have an important role in the pathobiology and prognosis of CML. This retrospective study aimed to evaluate the effects of bone marrow (BM) fibrosis on disease prognosis and the effects of specific tyrosine-kinase inhibitors (TKIs) on BM fibrosis in CML patients.

Source: Clinical Lymphoma, Myeloma and Leukemia - January 16, 2024 Category: Hematology Authors: Mehmet Sezgin Pepeler, Mesut T ıglıoglu, Simten Dagdas, Esra Ozhamacıoglu, Unsal Han, Aynur Albayrak, Mürüvvet Seda Aydın, Gülten Korkmaz, Merve Pamukcuoğlu, Funda Ceran, Murat Albayrak, Gülsüm Ozet Tags: Original Study Source Type: research